Free Trial

XTX Topco Ltd Has $1.11 Million Position in Maximus, Inc. (NYSE:MMS)

Maximus logo with Business Services background

XTX Topco Ltd raised its position in Maximus, Inc. (NYSE:MMS - Free Report) by 234.1% in the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 11,879 shares of the health services provider's stock after acquiring an additional 8,324 shares during the quarter. XTX Topco Ltd's holdings in Maximus were worth $1,107,000 at the end of the most recent reporting period.

A number of other large investors have also recently added to or reduced their stakes in MMS. Assenagon Asset Management S.A. lifted its stake in shares of Maximus by 277.0% during the 3rd quarter. Assenagon Asset Management S.A. now owns 878,894 shares of the health services provider's stock worth $81,878,000 after buying an additional 645,760 shares during the last quarter. Healthcare of Ontario Pension Plan Trust Fund raised its stake in Maximus by 942.9% in the 2nd quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 323,300 shares of the health services provider's stock worth $27,707,000 after purchasing an additional 292,300 shares in the last quarter. Millennium Management LLC raised its stake in Maximus by 150.4% in the 2nd quarter. Millennium Management LLC now owns 406,075 shares of the health services provider's stock worth $34,801,000 after purchasing an additional 243,890 shares in the last quarter. Sio Capital Management LLC acquired a new stake in Maximus in the 3rd quarter worth about $14,453,000. Finally, Algert Global LLC bought a new position in Maximus in the 2nd quarter valued at about $12,424,000. Institutional investors and hedge funds own 97.21% of the company's stock.

Maximus Price Performance

Shares of Maximus stock traded down $0.51 during midday trading on Tuesday, hitting $70.78. 649,472 shares of the company traded hands, compared to its average volume of 428,639. Maximus, Inc. has a 12 month low of $70.00 and a 12 month high of $93.97. The company has a debt-to-equity ratio of 0.59, a quick ratio of 1.49 and a current ratio of 1.49. The stock has a market cap of $4.27 billion, a price-to-earnings ratio of 14.16 and a beta of 0.73. The firm's fifty day moving average price is $83.83 and its 200-day moving average price is $86.92.

Maximus Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Saturday, November 30th. Shareholders of record on Friday, November 15th were issued a dividend of $0.30 per share. This represents a $1.20 dividend on an annualized basis and a yield of 1.70%. The ex-dividend date of this dividend was Friday, November 15th. Maximus's payout ratio is 24.00%.

Insiders Place Their Bets

In other news, insider Michelle F. Link sold 2,208 shares of the business's stock in a transaction that occurred on Tuesday, December 3rd. The shares were sold at an average price of $73.83, for a total value of $163,016.64. Following the transaction, the insider now owns 6,567 shares in the company, valued at approximately $484,841.61. The trade was a 25.16 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Insiders own 1.40% of the company's stock.

Wall Street Analysts Forecast Growth

Separately, StockNews.com lowered shares of Maximus from a "buy" rating to a "hold" rating in a report on Thursday, November 28th.

View Our Latest Research Report on MMS

Maximus Company Profile

(Free Report)

Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.

Featured Stories

Institutional Ownership by Quarter for Maximus (NYSE:MMS)

Should you invest $1,000 in Maximus right now?

Before you consider Maximus, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Maximus wasn't on the list.

While Maximus currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

These 7 Stocks Will Be Magnificent in 2025 Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

From Landfills to Profits: Opal Fuels CEO Shares How the Company Turns Trash into Cash
The Real Reason Tesla Stock Is Soaring – and Why Tech Expert Says It Won’t Stop
Best ETFs for 2025: Growth, Stability, and AI-Driven Investing

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines